Ranjani Raghavan

Mumbai

Senior Editor at Mint

journalist @ Mint. Covering the India investment & the deals ecosystem. Email - [email protected]

Featured in: Favicon

vccircle.com Favicon

hindustantimes.com Favicon

livemint.com Favicon

dealstreetasia.com Favicon

techcircle.in Favicon

htsyndication.com Favicon

inkl.com

gfmreview.com Favicon

flipboard.com Favicon

einnews.com

Articles

Advent-backed Kreditbee flips back to India, to merge entities ahead of IPO

2 weeks ago | livemint.com | Sneha Shah |Ranjani Raghavan

The move comes after the Bengaluru-based startup shifted its domicile to India after dissolving its Singapore parent, these people said. KreditBee has paid around $100 million in tax to move its headquarters to India, the second of the two persons cited earlier said, both of whom spoke on the condition of anonymity. “Finnovation Tech and KrazyBee, the two Indian entities having mirror shareholdings, are getting merged.
HT Syndication: Wockhardt pins US future on novel antibiotics, vacating US generics biz

3 weeks ago | htsyndication.com | Jessica Jani |Ranjani Raghavan

New Delhi, April 3 -- Wockhardt Ltd that built its name as a maker of generic drugs is shifting its focus in the US market to developing new antibiotics, turning away from generics and entering a space largely vacated by Big Pharma in recent years. The company is working on new antibiotics and has identified segments for a push into biosimilar drugs, chairman Habil Khorakiwala said, in the wake of promising results shown by Zaynich, an antibiotic it developed in-house.
Wockhardt pins US future on novel antibiotics, vacating US generics biz

3 weeks ago | livemint.com | Jessica Jani |Ranjani Raghavan

Companies Summary Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for weight loss and anti-diabetic medicine, as it pivots away from the US generics market This is a Mint Premium article gifted to you. Subscribe to enjoy similar stories.
HT Syndication: Investors look for an exit route from Resurgent Power

3 weeks ago | htsyndication.com | Ranjani Raghavan |Nehal Chaliawala

New Delhi, April 2 -- ICICI Venture and foreign investors who jointly own nearly three-fourths of Resurgent Power Ventures are planning to sell their stakes in the Tata Power-backed platform, two people aware of the development said. While Tata Power owns 26% of the Singapore-based company with assets worth $2.5 billion, the rest is owned by ICICI Venture, Kuwait Investment Authority, and Oman Investment Authority.
Investors look for an exit route from Resurgent Power

3 weeks ago | livemint.com | Ranjani Raghavan |Nehal Chaliawala

While Tata Power owns 26% of the Singapore-based company with assets worth $2.5 billion, the rest is owned by ICICI Venture, Kuwait Investment Authority, and Oman Investment Authority. “The shareholders have met investment banks to arrange a sale," one of the two people said on the condition of anonymity, adding a formal mandate is awaiting approval from Tata Power parent Tata Sons.
HT Syndication: ChrysCapital about to take a big bite of Theobroma

3 weeks ago | htsyndication.com | Ranjani Raghavan |Sneha Shah

New Delhi, March 31 -- Mumbai: Homegrown private equity firm ChrysCapital is poised to acquire a controlling stake in bakery chain Theobroma Foods for Rs.2,200-2,300 crore, two people aware of the development said. The deal will see the complete exit of ICICI Venture, which invested in the company in 2017. Theobroma founder Kainaz Messman and family may retain around 10% stake in the 194-store bakery network, the people cited above said on the condition of anonymity.
HT Syndication: Bain held on to Emcure after the IPO. Here's what's next

3 weeks ago | htsyndication.com | Sneha Shah |Ranjani Raghavan

Mumbai, March 31 -- Global private equity firm Bain Capital is looking to divest its stake in listed pharmaceutical manufacturer Emcure Pharmaceuticals Ltd through a substantial block deal, according to two people with knowledge of the development. The move comes after the lock-in period for selling the shares in the Pune-based company got over in February this year.
ChrysCapital about to take a big bite of Theobroma

3 weeks ago | livemint.com | Ranjani Raghavan |Sneha Shah

Companies Summary Theobroma founder Kainaz Messman and family may retain around 10% stake in the 194-store bakery network, the people cited above said on the condition of anonymity This is a Mint Premium article gifted to you. Subscribe to enjoy similar stories. Mumbai: Homegrown private equity firm ChrysCapital is poised to acquire a controlling stake in bakery chain Theobroma Foods for ₹2,200-2,300 crore, two people aware of the development said.
Bain held on to Emcure after the IPO. Here's what's next

3 weeks ago | livemint.com | Sneha Shah |Ranjani Raghavan

The move comes after the lock-in period for selling the shares in the Pune-based company got over in February this year. As per Indian market regulations, a lock-in period for certain categories such as anchor investors and pre-listing investors is mandatory, during which period they are prohibited from selling their shares. “Bain Capital is likely to sell stake worth over $200 million ( ₹1,700 crore) in the company.
Bain held on to Emcure after the IPO. Here's what's next

3 weeks ago | flipboard.com | Sneha Shah |Ranjani Raghavan

2 hours agoWhy won't India buy even a single bushel of American corn? That's the question US Commerce Secretary Howard Lutnick raised recently while criticising India's trade policies, taking a swipe at its market restrictions. In another interview, Lutnick accused India of blocking US farmers and urged it to …